Interim report
Page 1
. INTERIM REPORT JANUARY-SEPTEMBER 2026 Q3 July–September 2026 in brief • Net sales increased to SEK 2,849 M (2,646). Net sales grew organically by 6.0%. • The gross margin increased to 43.0% (41.1). • Adjusted EBITDA increased to SEK 523 M (436). • Adjusted operating profit increased to SEK 247 M (165). • Profit after financial items amounted to SEK 104 M (111). • Earnings per share before and after dilution amounted to SEK 0.21 (0.30). • Cash flow from operations rose to SEK 485 M (446), corresponding to a cash conversion of 100.4% (105.0). • A revaluation of the holdings in Atlas Mobility and Veplas of SEK 62 M was charged to net financial items. • New segment reporting based on the following: Europe, North America and International. Restated historical comparative figures are available on Arjo’s website. • Strengthening of the Arjo Management Team, read more on page 5. • Arjo’s new strategic direction was presented at the Capital Markets Day, including a commitment to improve EBIT by approximately SEK 350 M versus 2025. Financial summary SEK M Quarter 3 2026 Quarter 3 2025 Jan–Sep 2026 Jan–Sep 2025 Rolling 12 months Full-year 2025 Net sales 2,849 2,646 8,306 8,186 11,119 11,000 Gross profit 1,226 1,088 3,537 3,499 4,722 4,684 Gross margin, % 43.0 41.1 42.6 42.7 42.5 42.6 Adjusted EBITDA1) 523 436 1,462 1,396 1,987 1,922 Adjusted EBITDA margin, %1) 18.4 16.5 17.6 17.1 17.9 17.5 Adjusted EBITA1) 314 228 847 768 1,170 1,091 Adjusted EBITA margin, %1) 11.0 8.6 10.2 9.4 10.5 9.9 Operating profit (EBIT) 206 152 601 494 783 675 Adjusted operating profit (EBIT)1) 247 165 648 581 897 831 Profit after financial items 104 111 424 362 528 467 Net profit for the period 58 81 291 264 362 334 Number of shares, thousands 272,370 272,370 272,370 272,370 272,370 272,370 Earnings per share, SEK 0.21 0.30 1.07 0.97 1.33 1.23 Cash flow from operations 485 446 979 835 1,579 1,435 Cash conversion, % 100.4 105.0 69.2 63.7 82.4 79.3 1. Before exceptional items. See Alternative performance measures on page 18 and Definitions on page 21. ANDRÉAS ELGAARD PRESIDENT AND CEO “With 6% organic growth in the quarter, we continue to grow and strengthen our profitability. Our focus now is on turning our strategy into results and gradu- ally building a stronger Arjo for the future.” Solid growth and a strategy for greater value creation ARJO INTERIM REPORT JANUARY–SEPTEMBER 2026 1
Page 2
CEO’S COMMENTS measures within existing operations and applies regardless of whether it is based on reported or adjusted EBIT. Impact is expected to increase gradually from 2027, with most effects realized in 2028 and full impact achieved by mid-2029. The implementation is expected to result in restructuring costs of approximately SEK 370 M, primarily over the next 18 months. The EBIT improvement is the first tangible step in imple - menting the strategy and shows the expected impact of the measures presented. At the same time, we continue to work on several strategic initiatives and will present updated finan - cial targets for growth, profitability and capital efficiency during the first quarter of 2027. Focus on customers and implementation Arjo’s potential is particularly clear when we work closely with our customers and make use of the full breadth of our offering. During the quarter, we entered into a strategic part - nership with a major elderly care provider in Australia. By combining the Arjo Insight analysis tool with clinical exper - tise, training and products from various parts of our offering, we can help improve care outcomes and the work environ - ment, while making more efficient use of resources. This partnership is a good example of how close customer rela - tionships and a broader perspective can create greater value for both our customers and Arjo. We continued to strengthen the Arjo Management Team during the quarter. The aim is to increase our customer focus, improve how we collaborate to develop our offering and accelerate the pace of change in our ambition to mod - ernize Arjo. We have an important task ahead of us. We presented our strategic direction and priorities at the Capital Markets Day. Together, we will now step by step deliver on what we have promised. From 2027, we will continuously report on progress and the results we deliver. ANDRÉAS ELGAARD PRESIDENT & CEO We continued to perform well in the third quarter, with organic growth of 6%. While a tariff refund contributed to earnings for the quarter, the underlying profitability trend is positive, reflecting continued high demand for our products and solutions, an improved gross margin, and a continued focus on efficiency. Our ongoing evaluation of previous investments resulted in a revaluation of the holdings in Atlas Mobility and Veplas, which impacted net financial items for the quarter. As previously announced, from the third quarter, we will report our operations in the three segments of North Amer - ica, Europe and International. North America grew organi - cally more than 6% during the quarter, and Europe more than 7%, with broad, positive performance in several mar - kets. International performed in line with the comparative quarter, with continued solid sales growth in countries including Australia and India. We continue to grow in a market with strong long-term drivers. An aging population, growing healthcare needs and a continued shortage of healthcare staff are increasing the need for solutions that improve safety, efficiency and quality in healthcare. Arjo holds a strong position in this area, with close customer relationships and a broad offering. A strategy for a stronger Arjo We presented our new strategic direction at our Capital Markets Day in September. We will strengthen our perfor - mance by focusing on our core strengths, becoming more customer-focused, streamlining the operations and using our resources more efficiently. The intention is to build a stron - ger Arjo today, while creating better conditions for profit - able growth in the future from a more scalable base. As a first step, we have committed to improving EBIT by approximately SEK 350 M versus 2025. This improvement will be driven mainly by a more effective operating model and enhanced procurement focus, and is not dependent on future growth. The improvement in profitability comes from Solid growth and a strategy for greater value creation Solid organic growth 6.0% Q3 ARJO INTERIM REPORT JANUARY–SEPTEMBER 2026 2
Page 3
GROUP PERFORMANCE Group performance Net sales and results Third quarter of 2026 Net sales for the quarter amounted to SEK 2,849 M (2,646), corre - sponding to an organic increase of 6.0%. Sales in North America increased organically by 6.4%. The US grew by more than 7% organically, driven by a positive trend in patient han - dling, service and diagnostics. Sales in Canada also performed well during the quarter. Sales in Europe increased organically by 7.4%, driven by healthy demand in rental solutions and service. Countries such as France, Italy, Poland, and the Netherlands performed well, while sales were slightly weaker in the UK. International performed in line with the comparative quarter, with continued solid sales growth in countries such as Australia and India. The gross margin increased to 43.0% (41.1). Positive mix effects off - set higher material and transportation costs, while tariffs had a positive impact of approximately 1.6 percentage points on the gross margin. Adjusted for US tariff refund of approximately SEK 35 M and a SEK 11 M decrease in tariff costs, the gross margin improved slightly year on year. Operating expenses for the quarter increased slightly to SEK 984 M (925), primarily due to higher variable selling expenses. Exceptional items amounted to SEK 41 M (13) and relates to costs for the completed strategic review and restructuring costs attributable to activities to enhance efficiency in the Group’s sales organization. Adjusted EBITDA increased to SEK 523 M (436) and the adjusted EBITDA margin increased to 18.4% (16.5). Operating profit amounted to SEK 206 M (152) and adjusted operating profit to SEK 247 M (165). Net financial items for the quarter amounted to SEK -102 M (-41). A revaluation of Arjo’s holdings in Atlas Mobility and Veplas of SEK 62 M was charged to net financial items. The revaluation reflects a change to the assessment of the value of the holdings and means that both holdings are now valued at zero. Positive currency effects in net finan - cial items amounted to SEK 6 M (2) for the quarter. Profit before tax amounted to SEK 104 M (111). Tax expense for the period amounted to SEK 46 M (30). The effective tax rate increased as a result of the revaluations described above. Net profit for the period amounted to SEK 58 M (81) and earnings per share amounted to SEK 0.21 (0.30). SEK M Quarter 3 2026 Quarter 3 20251) Organic change Jan–Sep 2026 Jan–Sep 20251) Organic change Rolling 12 months Full-year 20251) Europe 1,348 1,248 7.4% 3,907 3,801 4.9% 5,278 5,172 North America 1,087 1,006 6.4% 3,207 3,286 3.2% 4,280 4,359 International 414 392 0.5% 1,192 1,099 9.3% 1,561 1,469 Total 2,849 2,646 6.0% 8,306 8,186 4.8% 11,119 11,000 1. The figures for 2025 have been restated following a new segment reporting. Net sales per segment January–September 2026 Net sales for the period amounted to SEK 8,306 M (8,186), correspond - ing to an organic increase of 4.8%. Organic growth in North America was 3.2%, with a favorable sales trend in capital goods and service. The US performed positively, while Canada saw a slight decline in relation to a strong comparative period last year. Sales in Europe increased organically by 4.9%. Demand was healthy in several European markets such as France, Italy and Poland. International grew by 9.3% organically during the period, driven by a solid performance in markets including India, South Africa, Australia and New Zealand. The gross margin was in line with the comparative period year at 42.6% (42.7). Operating expenses for the period amounted to SEK 2,901 M (2,885). Adjusted EBITDA for the period amounted to SEK 1,462 M (1,396). The adjusted EBITDA margin was 17.6% (17.1). Operating profit amounted to SEK 601 M (494) and adjusted operat - ing profit to SEK 648 M (581). Net financial items amounted to SEK -177 M (-132) for the period. A revaluation of Arjo’s holdings in Atlas Mobility and Veplas of SEK 62 M was charged to net financial items. Positive currency effects in net finan - cial items amounted to SEK 23 M (9) for the period. Profit before tax increased to SEK 424 M (362). Tax expense for the period amounted to SEK 132 M (98). The effective tax rate increased as a result of the revaluations described above. Net profit for the period amounted to SEK 291 M (264) and earnings per share amounted to SEK 1.07 (0.97). Q3 ARJO INTERIM REPORT JANUARY–SEPTEMBER 2026 3
Page 4
GROUP PERFORMANCE Currency effects SEK M Quarter 3 2026 Jan–Sep 2026 Translation effect (vs 2025) Sales +39 -284 Cost of goods sold –25 +172 Gross profit +15 –112 Operating expenses –10 +80 Restructuring and other operating income/expenses +0 +1 Total translation effect, EBIT +5 –30 Transaction effect (vs 2025) Cost of goods sold +2 –17 Recognized remeasurement effects Other operating income/expenses +4 +3 Translation effects for the quarter amounted to SEK +5 M and transac - tion effects to SEK +2 M. In addition, the recognized revaluation effects of operating receivables and liabilities amounted to SEK +4 M for the quarter. Cash flow and financial position Cash flow from operations amounted to SEK 485 M (446) for the quar - ter. The positive cash flow from working capital was SEK 67 M (83). Cash conversion for the quarter was 100.4% (105.0). Net investments for the quarter amounted to SEK 177 M (142), divided between tangible assets of SEK 108 M (76) and intangible assets of SEK 69 M (67). The investments in tangible assets include investments in the rental fleet of SEK 76 M (48). The Group’s cash and cash equivalents amounted to SEK 858 M (705) and interest-bearing net debt was SEK 4,240 M (4,500). Arjo has contracted unutilized credit facilities of SEK 2,799 M (4,724) available for refinancing outstanding commercial paper. The equity/assets ratio amounted to 50.3% (49.5). Net debt/adjusted EBITDA was 2.2 (2.2). Research and development Arjo’s gross research and development costs for the quarter amounted to SEK 68 M (67), of which SEK 35 M (34) was charged to operating profit, see also Note 4. The gross costs correspond to 2.4% (2.5) of consolidated net sales. Outlook 2026 Organic sales growth for 2026 is expected to be within the Group’s target interval of 3–5%. Other information Nomination Committee ahead of 2027 Annual General Meeting In accordance with the resolution of Arjo’s 2020 Annual General Meeting, the Nomination Committee in respect of the Annual General Meeting shall be composed of members appointed by the three largest share - holders in terms of voting rights, based on a list of owner-registered shareholders from Euroclear Sweden AB or other reliable ownership information, as of August 31 of each year, and the Chairman of the Board of Directors. In addition, if the Chairman of the Board, in consultation with the member appointed by the largest shareholder in terms of voting rights, deems it appropriate, it shall include an, in relation to the company and its major shareholders, independent representative of the minor shareholders as a member of the Nomination Committee. Ahead of the 2027 Annual General Meeting, Arjo’s Nomination Committee comprised Chairman Carl Bennet (Carl Bennet AB), Anna Magnusson (Fourth Swedish National Pension Fund), Anders Oscarsson (Svolder), as well as Board Chairman Johan Malmquist. Shareholders who would like to submit proposals to Arjo’s Nomination Committee ahead of the 2027 Annual General Meeting can contact the Nomination Committee by e-mail at nominating.committee@arjo.com or by mail: Arjo AB, Att: Nomination Committee, Hans Michelsensgatan 10, SE-211 20 Malmö, Sweden. The deadline for submitting a proposal to the Nomination Committee is December 31, 2026. 2027 Annual General Meeting Arjo’s Annual General Meeting will be held on April 19, 2027 in Malmö, Sweden. Shareholders wishing to have a matter addressed at the AGM can submit their proposal to Arjo’s Board Chairman by e-mail: agm@arjo.com , or by mail: Arjo AB, Att: Bolagsstämmoärenden, Hans Michelsensgatan 10, SE-211 20 Malmö, Sweden. To ensure inclusion in the notice and thus in the Annual General Meeting’s agenda, proposals must be received by the company by March 1, 2027. Transactions with related parties Transactions between Arjo and companies in Getinge Group are specified in Note 10. Forward-looking information This report contains forward-looking information based on the current expectations of Arjo’s Management Team. Although management con - siders the expectations presented by such forward-looking information to be reasonable, there is no guarantee that these expectations will prove correct. Consequently, actual outcomes may vary considerably compared with what is stated in the forward-looking information, due to such factors as changed conditions regarding the economy, market and competition, changes in legal and regulatory requirements, as well as other policy measures and fluctuations in exchange rates. Q3 ARJO INTERIM REPORT JANUARY–SEPTEMBER 2026 4
Page 5
New strategy and improved profitability At the Capital Markets Day in September, Arjo presented a new strategy to strengthen performance by focusing on core strengths, becoming more customer-centric, streamlining operations and using resources more efficiently. The strategy is intended to build a stronger Arjo today, while creating better conditions for profitable growth in the future from a more scalable base. As a first step Arjo is commited to improving EBIT by approximately SEK 350 M versus 2025. The improvement will be driven mainly by a more effective operating model and enhanced procurement focus, and is not dependent on future growth. The improvement in profitability comes from measures within existing operations and applies regardless of whether it is based on reported or adjusted EBIT. The earnings effects are expected to increase gradually from 2027, with most effects realized in 2028 and the full effect achieved by mid-2029. The implementation is expected to result in restructuring costs of approximately SEK 370 M, primarily over the next 18 months. The EBIT improvement is the first tangible step in implementing the strategy and outlines the expected impact of the measures presented. At the same time, Arjo is continuing to carry out several strategic initia - tives and will present updated financial targets for growth, profitability and capital efficiency during the first quarter of 2027. New segment reporting During the quarter, Arjo introduced a new segment reporting structure based on three geographic segments. The new segment reporting struc - ture is intended to provide investors with a more relevant and useful overview of Arjo’s business by bringing together financially and com - mercially similar markets into the three reportable segments: Europe, North America and International. The change also reflects Arjo’s ongo - ing transformation journey and its new operating model, with greater collaboration and a more integrated way of working between markets within each respective segment. To ensure comparability with historical periods, restated historical comparative figures for the 2024 and 2025 fiscal years and the last ten quarters (Q1 2024–Q2 2026) are available on Arjo’s website. The restatement does not affect Arjo’s previously recognized total sales or earnings. Changes to the Arjo Management Team During the quarter, Martin Waldén assumed the position of Executive Vice President of the new Group function, Group Sales & Group Trans - formation. The function will be responsible for driving Arjo’s transfor - mation agenda and developing its commercial capabilities. Martin Waldén has extensive experience in strategic and commercial change management from senior roles at PwC and Accenture Strategy Consult - ing, and from commercial and strategic line management positions. He took up his role on August 1. As previously announced, Arjo has also appointed Lisa Ekelund as its new CFO. Lisa Ekelund has extensive international experience from senior finance and business leadership positions. She most recently served as CFO of Polestar Nordics, and was previously Vice President and CFO at Saab Surveillance and held several senior finance leadership positions in Volvo Group. Lisa will take office in early November and succeed Christofer Carlsson, who will leave Arjo by the end of January 2027. Moreover, Arjo has established a new Group function called Group Portfolio. This function will assume overall responsibility for product strategy, portfolio management, innovation and product development, with the aim of sharpening priorities, strengthening execution and improving capabilities to develop and launch competitive solutions. The function will be led by Jennie Borgström, who has been appointed Exec - utive Vice President, Group Portfolio, and a member of the Arjo Man - agement Team, effective November 1. Jennie Borgström has extensive international experience from senior positions at Alfa Laval. In connec - tion with this change, Tobias Kramer, Executive Vice President Global Marketing, has decided to leave Arjo. Other events Q3 ARJO INTERIM REPORT JANUARY–SEPTEMBER 2026 5 OTHER EVENTS
Page 6
Q3 ARJO INTERIM REPORT JANUARY–SEPTEMBER 2026 6 OTHER INFORMATION Arjo sells products and services through its own companies and distributors to customers in more than 100 countries. The Group has suppliers of direct materials in more than 50 countries and production in five countries. The company is thus exposed to a number of strategic, operational, financial and regulatory risks, and risk management is a natural element of day-to-day operations. The company’s risks are identified and evaluated under the framework of Arjo’s Enterprise Risk Management (ERM) process. Managing and preventing risks are important aspects of Arjo’s strategic planning process and internal control process, and encompass all business areas and Group functions. Identified risks are continuously evaluated and measures are taken to mitigate potential negative effects. The results of risk management activities are regularly reported to the Management Team and the Board. Arjo’s long-term risks that are deemed to have the greatest impact on its operations include changes in healthcare reimbursement systems and regulatory requirements, product quality and product safety, research and development, cybersecurity and information security and risks in the value chain. For more information about the long-term risks related to Arjo, as well as the Group’s risk exposure and risk management, refer to the 2025 Annual Report, which is available at www.arjo.com . Risk management at Arjo
Page 7
Assurance The Board of Directors and CEO assure that the interim report provides a true and fair review of the Parent Company and the Group’s operations, position and earnings and describes the material risks and uncertainties faced by the Parent Company and the Group. Malmö, October 22, 2026 Johan Malmquist Chairman of the Board Carl Bennet Vice Chairman of the Board Ulrika Dellby Board member Eva Elmstedt Board member Dan Frohm Board member Ulf Grunander Board member Carola Lemne Board member Andréas Elgaard President & CEO Madeléne Carlsson Board member Employee representative Kajsa Haraldsson Board member Employee representative Q3 ARJO INTERIM REPORT JANUARY–SEPTEMBER 2026 7 ASSURANCE
Page 8
ARJO INTERIM REPORT JANUARY-SEPTEMBER 20268 Review report Arjo AB (publ) Corp.reg.no 559092-8064 To the Board of Directors of Arjo AB (publ) Introduction We have reviewed the condensed interim report of Arjo AB (publ) as of September 30, 2026 and the nine months period that ended. The board of Directors and the Managing Director are responsible for the preparation and presentation of this interim report in accordance with IAS 34 and the Swedish Annual Accounts Act. Our responsibility is to express a conclusion on this interim report based on our review. Scope of review We conducted our review in accordance with the International Standard on Review Engagements, ISRE 2410 Review of Interim Report Performed by the Independent Auditor of the Entity. A review consists of making inquiries, primarily of persons responsible for financial and accounting matters, and applying analytical and other review procedures. A review is substantially less in scope than an audit conducted in accordance with International Standards on Auditing and other generally accepted auditing standards in Sweden. The procedures performed in a review do not enable us to obtain assurance that we would become aware of all significant matters that might be identified in an audit. Accordingly, we do not express an audit opinion. Conclusion Based on our review, nothing has come to our attention that causes us to believe that the interim report is not prepared, in all material respects, in accordance with IAS 34 and the Swedish Annual Accounts Act regarding the Group, and in accordance with the Swedish Annual Accounts Act regarding the Parent Company. Malmö, October 22, 2026 Ernst & Young AB Karoline Tedevall Authorized Public Accountant
Page 9
ARJO INTERIM REPORT JANUARY-SEPTEMBER 20269 Q3 Consolidated financial statements CONDENSED CONSOLIDATED INCOME STATEMENT SEK M Note Quarter 3 2026 Quarter 3 2025 Jan - Sep 2026 Jan - Sep 2025 Full-year 2025 Net sales 2 2,849 2,646 8,306 8,186 11,000 Cost of goods sold -1,624 -1,558 -4,769 -4,687 -6,315 Gross profit 1,226 1,088 3,537 3,499 4,684 Selling expenses -562 -536 -1,667 -1,669 -2,211 Administrative expenses -387 -355 -1,127 -1,105 -1,463 Research and development costs 4 -35 -34 -107 -112 -140 Exceptional items 5 -41 -13 -47 -87 -155 Other operating income 4 7 14 10 12 Other operating expenses 0 -5 -2 -42 -52 Operating profit (EBIT) 3 206 152 601 494 675 Net financial items 6 -102 -41 -177 -132 -209 Profit after financial items 104 111 424 362 467 Taxes -46 -30 -132 -98 -132 Net Profit for the period 58 81 291 264 334 Attributable to: Parent Company shareholders 58 81 291 264 334 Number of shares, thousands 272,370 272,370 272,370 272,370 272,370 Earnings per share, SEK1) 0.21 0.30 1.07 0.97 1.23 1. Before and after dilution. For definition, see page 21.
Page 10
ARJO INTERIM REPORT JANUARY-SEPTEMBER 202610 Q3 CONDENSED CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME SEK M Quarter 3 2026 Quarter 3 2025 Jan - Sep 2026 Jan - Sep 2025 Full-year 2025 Net profit for the period 58 81 291 264 334 Other comprehensive income Items that cannot be restated in profit Actuarial gains/losses pertaining to defined-benefit pension plans -37 9 -7 -3 -2 Tax attributable to items that cannot be restated in profit 9 -3 2 22 20 Items that can later be restated in profit Translation differences 222 -129 550 -956 -1,131 Hedges of net investments -1 9 3 67 101 Cash-flow hedges 45 7 39 1 8 Tax attributable to items that can be restated in profit -26 7 -48 43 48 Other comprehensive income for the period, net after tax 213 -98 539 -825 -957 Total comprehensive income for the period 271 -17 831 -561 -622 Comprehensive income attributable to: Parent Company shareholders 271 -17 831 -561 -622
Page 11
ARJO INTERIM REPORT JANUARY-SEPTEMBER 202611 Q3 CONDENSED CONSOLIDATED BALANCE SHEET SEK M Note Sep 30, 2026 Sep 30, 2025 Dec 31, 2025 Assets Intangible assets 7,469 7,295 7,215 Tangible assets 1,586 1,539 1,486 Tangible lease assets 1,229 1,131 1,214 Financial assets 7 828 847 739 Total non-current assets 11,112 10,813 10,654 Inventories 1,415 1,353 1,177 Accounts receivable 1,888 1,656 1,617 Current financial receivables 7 23 28 27 Other current receivables 526 513 548 Cash and cash equivalents 7 858 705 836 Assets held for sale 129 122 119 Total current assets 4,840 4,377 4,323 Total assets 15,953 15,190 14,977 Shareholders' equity and liabilities Shareholders' equity 8,029 7,519 7,457 Equity attributable to the Parent Company 8,029 7,519 7,457 Non-current financial liabilities 7 2,642 2,976 2,637 Non-current lease liabilities 7 882 779 858 Provisions for pensions, interest-bearing 7 36 35 34 Other provisions, non-current 281 224 229 Total non-current liabilities 3,840 4,013 3,757 Other provisions, current 58 55 56 Current financial liabilities 7 1,418 1,317 1,450 Current lease liabilities 7 412 403 408 Accounts payable 615 505 508 Other non-interest-bearing liabilities 1,581 1,378 1,339 Total current liabilities 4,083 3,657 3,762 Total shareholders' equity and liabilities 15,953 15,190 14,977 CONDENSED CHANGES IN SHAREHOLDERS´ EQUITY FOR THE GROUP SEK M Share Capital Reserves Retained earnings Total share- holders´ equity1) Opening balance at January 1, 2025 91 1,807 6,440 8,338 Net profit for the period - - 334 334 Other comprehensive income for the period, net after tax - -975 18 -957 Total comprehensive income for the period - -975 352 -622 Dividend - - -259 -259 Closing balance at December 31, 2025 91 832 6,534 7,457 Opening balance at January 1, 2026 91 832 6,534 7,457 Net profit for the period - - 291 291 Other comprehensive income for the period, net after tax - 544 -5 539 Total comprehensive income for the period - 544 286 831 Dividend - - -259 -259 Closing balance at September 30, 2026 91 1,377 6,562 8,029 1. Fully attributable to Parent Company shareholders.
Page 12
ARJO INTERIM REPORT JANUARY-SEPTEMBER 202612 Q3 CONDENSED CONSOLIDATED CASH-FLOW STATEMENT SEK M Note Quarter 3 2026 Quarter 3 2025 Jan - Sep 2026 Jan - Sep 2025 Full-year 2025 Operating activities Operating profit (EBIT) 206 152 601 494 675 Add-back of amortization, depreciation and write-down 3 277 273 813 817 1,136 Other non-cash items 19 23 20 -8 -15 Expensed exceptional items1) 41 11 47 85 109 Paid exceptional items -45 -23 -57 -80 -105 Financial items -40 -36 -128 -137 -177 Taxes paid -40 -37 -121 -151 -208 Cash flow before changes to working capital 418 363 1,176 1,020 1,415 Changes in working capital Inventories -82 -12 -161 -94 77 Current receivables 1 98 -211 9 13 Current liabilities 148 -3 174 -99 -70 Cash flow from operations 485 446 979 835 1,435 Investing activities Acquired operations 11 - -5 -30 -8 -27 Net investments -177 -142 -476 -526 -678 Cash flow from investing activities -177 -148 -506 -534 -705 Financing activities Raising of loans 1,112 3,274 5,150 15,930 19,736 Repayment of financial liabilities -1,336 -3,490 -5,179 -15,705 -19,687 Repayment of lease liabilities -109 -121 -326 -343 -449 Change in pension assets/liabilities -1 -4 -4 -7 -8 Change in interest-bearing receivables 8 7 12 46 49 Dividend - - -259 -259 -259 Realized derivatives attributable to financing activities 64 -20 79 -112 -113 Cash flow from financing activities -262 -354 -528 -449 -730 Cash flow for the period 46 -56 -55 -147 0 Cash and cash equivalents at the beginning of the period 818 766 836 892 892 Translation differences -6 -5 77 -39 -56 Cash and cash equivalents at the end of the period 858 705 858 705 836 1. Excluding write-down of non-current assets.
Page 13
ARJO INTERIM REPORT JANUARY-SEPTEMBER 202613 Q3 1 Accounting policies The Group's interim report has been prepared in accordance with IAS 34 Interim Financial Reporting and the applicable rules of Swedish Annual Accounts Act. The Parent Company has prepared the interim report in accordance with the Swedish Annual Accounts Act (1995:1554) and the Swedish Sustainability and Financial Reporting Board's recommendation RFR 2, Accounting for Legal Entities. The accounting policies applied in the preparation of this interim report apply to all periods and are consistent with the accounting policies presented in the 2025 Annual Report, published on www.arjo.com. No new or changed accounting standards that came into effect on January 1, 2026 had a material impact on Arjo. Arjo has decided not to apply in advance new standards, amendments or interpretations that have been published but will not come into effect until the fiscal year beginning on or after January 1, 2027. IFRS 18 Presentation and Disclosure in Financial Statements will be applied by the Arjo Group from January 1, 2027. Arjo is currently assessing the impact that the standard will have on the Group’s financial reporting. The standard is expected primarily to affect presentation of the statement of profit or loss, including the classification of income and expenses within the operating, investing and financing categories, as well as the introduction of new subtotals. The standard is not expected to affect the Group’s reported profit. IFRS 18 also introduces enhanced disclosure requirements relating to Management Performance Measures. Arjo is currently assessing which performance measures fall within the scope of the definition and how these measures should be presented. The totals in the tables and calculations do not always add up due to rounding differences. Each subtotal corresponds with its original source, which can lead to rounding differences in the totals. The holding in Bruin Biometrics LLC (BBI) has been classified as an asset held for sale since the fourth quarter of 2024. Due to circumstances beyond Arjo’s control, the sales process has taken longer than expected. Based on the current status of the sales process and Arjo’s continued intention to divest the holding, the classification is considered to remain as of the balance sheet date. 2 Segment reporting Quarter 3 2026 Quarter 3 20251) SEK M Europe North America Inter- national Group functions Arjo Group Europe North America Inter- national Group functions Arjo Group Product sales 648 658 274 - 1,580 573 605 267 - 1,445 Service incl. spare parts 327 185 74 - 585 317 166 68 - 551 Revenue from contracts with customers 975 843 348 - 2,166 890 771 335 - 1,996 Rental 373 244 66 - 684 358 235 57 - 650 Total net sales 1,348 1,087 414 - 2,849 1,248 1,006 392 - 2,646 Operating profit/loss 232 257 51 -334 206 164 200 63 -275 152 Net financial items -102 -41 Profit after financial items 104 111 Taxes -46 -30 Net profit for the period 58 81 Jan - Sep 2026 Jan - Sep 20251) SEK M Europe North America Inter- national Group functions Arjo Group Europe North America Inter- national Group functions Arjo Group Product sales 1,852 1,961 795 - 4,608 1,753 1,987 727 - 4,468 Service incl. spare parts 954 521 210 - 1,685 946 520 191 - 1,657 Revenue from contracts with customers 2,807 2,482 1,005 - 6,294 2,699 2,508 918 - 6,125 Rental 1,100 725 187 - 2,012 1,102 778 181 - 2,061 Total net sales 3,907 3,207 1,192 - 8,306 3,801 3,286 1,099 - 8,186 Operating profit/loss 621 770 173 -962 601 556 747 127 -936 494 Net financial items -177 -132 Profit after financial items 424 362 Taxes -132 -98 Net profit for the period 291 264 1. The segment reporting for 2025 has been restated as described below.
Page 14
ARJO INTERIM REPORT JANUARY-SEPTEMBER 202614 Q3 Segment reporting, cont. Full-year 20251) SEK M Europe North America Inter- national Group functions Arjo Group Product sales 2,419 2,644 970 - 6,033 Service incl. spare parts 1,280 689 261 - 2,229 Revenue from contracts with customers 3,699 3,333 1,230 - 8,262 Rental 1,473 1,026 239 - 2,737 Total net sales 5,172 4,359 1,469 - 11,000 Operating profit/loss 810 960 176 -1,271 675 Net financial items -209 Profit after financial items 467 Taxes -132 Net profit for the period 334 1. The segment reporting for 2025 has been restated as described below. Arjo monitors its operations within the segments Europe, North America and International (includes distributor markets in Eastern Europe). The segment structure was revised in the third quarter of 2026 as a result of Arjo’s new strategic direction. Comparative figures have been restated to reflect the new segment reporting structure. Restated historical quarterly data for the period from the first quarter of 2024 to the second quarter of 2026 are available on the Company’s website www.arjo.com. The principles for measuring segment results remain consistent with those applied in the 2025 Annual Report. Arjo has significant central Group functions in the areas of Supply Chain (product supply, inventory, and distribution), IT, Quality, and Research and Development. Costs of goods sold within the Supply Chain are allocated to each segment. The remaining expenses for the Group functions are recognized as Group expenses. Assets and liabilities are not divided by segment since no such amounts are regularly reported to the chief operating decision maker. 3 Depreciation/amortization and write-down SEK M Quarter 3 2026 Quarter 3 2025 Jan - Sep 2026 Jan - Sep 2025 Full-year 2025 Intangible assets -67 -63 -199 -187 -296 Of which, attributable to acquisitions -18 -17 -52 -53 -70 Tangible assets -97 -99 -281 -298 -399 Tangible lease assets -113 -111 -333 -332 -441 Total -277 -273 -813 -817 -1,136 Of which, write-down - -2 - -2 -44 Depreciation/amortization and write-downs by function, SEK M Quarter 3 2026 Quarter 3 2025 Jan - Sep 2026 Jan - Sep 2025 Full-year 2025 Cost of goods sold -184 -181 -538 -543 -722 Selling expenses -44 -41 -128 -125 -170 Administrative expenses -47 -47 -143 -142 -192 Research and development costs -2 -2 -5 -5 -7 Exceptional items - -2 - -2 -44 Total -277 -273 -813 -817 -1,136 Of which, write-down - -2 - -2 -44
Page 15
ARJO INTERIM REPORT JANUARY-SEPTEMBER 202615 Q3 4 Research and development costs SEK M Quarter 3 2026 Quarter 3 2025 Jan - Sep 2026 Jan - Sep 2025 Full-year 2025 Research and development costs, gross -68 -67 -214 -234 -303 Capitalized development costs 33 33 108 122 163 Research and development costs, net -35 -34 -107 -112 -140 5 Exceptional items SEK M Quarter 3 2026 Quarter 3 2025 Jan - Sep 2026 Jan - Sep 2025 Full-year 2025 Acquisition expenses - 0 0 -1 -2 Impairment of ERP system - - - - -35 Restructuring and integration costs1) -41 -13 -47 -86 -118 Total -41 -13 -47 -87 -155 1. The amount for 2026 relates to costs associated with the completed strategic review, as well as restructuring costs related to activities to improve the efficiency of the Group’s sales organization. Exceptional items by function, SEK M Quarter 3 2026 Quarter 3 2025 Jan - Sep 2026 Jan - Sep 2025 Full-year 2025 Cost of goods sold -2 -3 -2 -34 -46 Selling expenses -3 -2 -5 -10 -20 Administrative expenses -36 -6 -37 -40 -86 Research and development costs - -1 -2 -1 -1 Other operating expenses 0 0 0 -2 -2 Total -41 -13 -47 -87 -155 The table above presents the function in which the items would have been recognized had they not been classified as exceptional items.
Page 16
ARJO INTERIM REPORT JANUARY-SEPTEMBER 202616 Q3 6 Financial assets and liabilities measured at fair value Sep 30, 2026, SEK M Assets/liabilities measured at fair value through profit or loss Derivatives used for hedging purposes Total Other current receivables, derivatives 1 - 1 Other financial assets1) 1 45 47 Total assets 2 45 47 Other non-interest-bearing liabilities, derivatives 7 - 7 Total liabilities 7 - 7 Sep 30, 2025, SEK M Assets/liabilities measured at fair value through profit or loss Derivatives used for hedging purposes Total Other current receivables, derivatives 8 - 8 Other financial assets 98 - 98 Total assets 107 - 107 Other non-interest-bearing liabilities, derivatives 6 1 7 Total liabilities 6 1 7 Dec 31, 2025, SEK M Assets/liabilities measured at fair value through profit or loss Derivatives used for hedging purposes Total Other current receivables, derivatives 4 - 4 Other financial assets1) 63 6 69 Total assets 67 6 73 Other non-interest-bearing liabilities, derivatives 3 - 3 Total liabilities 3 - 3 1. During the quarter, other non-current financial assets were remeasured by SEK -62 M. During the fourth quarter of 2025, they were remeasured by SEK -35 M. For a description of valuation techniques and inputs used in the valuation, please refer to Note 28 in the Annual Report for 2025. For other financial assets and liabilities in the Group, the reported values represent a reasonable approximation of their fair values. 7 Consolidated interest-bearing net debt SEK M Sep 30, 2026 Sep 30, 2025 Dec 31, 2025 Non-current financial liabilities 2,642 2,976 2,637 Non-current lease liabilities 882 779 858 Current financial liabilities 1,418 1,317 1,450 Current lease liabilities 412 403 408 Provisions for pensions 36 35 34 Interest-bearing liabilities 5,389 5,510 5,387 Less financial receivables -65 -90 -82 Less pension assets -227 -213 -214 Less cash and cash equivalents -858 -705 -836 Interest-bearing net debt 4,240 4,500 4,255
Page 17
ARJO INTERIM REPORT JANUARY-SEPTEMBER 202617 Q3 8 Key figures for the Group SEK M Quarter 3 2026 Quarter 3 2025 Jan - Sep 2026 Jan - Sep 2025 Full-year 2025 Sales measures Net sales 2,849 2,646 8,306 8,186 11,000 Net sales growth, % 7.7 -3.2 1.5 -1.4 -2.6 Organic growth in sales, % 6.0 3.8 4.8 3.4 3.4 Expense measures Selling expenses as a % of net sales 19.7 20.2 20.1 20.4 20.1 Administrative expenses as a % of net sales 13.6 13.4 13.6 13.5 13.3 Research and development costs gross as a % of net sales 2.4 2.5 2.6 2.9 2.8 Earnings measures EBITDA 483 425 1,415 1,311 1,811 EBITDA growth, % 13.7 -0.9 7.9 -6.0 -8.4 Adjusted EBITDA1) 523 436 1,462 1,396 1,922 EBITA 273 215 800 681 971 Adjusted EBITA1) 314 228 847 768 1,091 Operating profit (EBIT) 206 152 601 494 675 Adjusted operating profit (EBIT)1) 247 165 648 581 831 Earnings per share, SEK 0.21 0.30 1.07 0.97 1.23 Margin measures Gross margin, % 43.0 41.1 42.6 42.7 42.6 EBITDA margin, % 16.9 16.0 17.0 16.0 16.5 Adjusted EBITDA margin, %1) 18.4 16.5 17.6 17.1 17.5 EBITA margin, % 9.6 8.1 9.6 8.3 8.8 Adjusted EBITA margin, %1) 11.0 8.6 10.2 9.4 9.9 Operating margin, % 7.2 5.7 7.2 6.0 6.1 Adjusted Operating margin, %1) 8.7 6.2 7.8 7.1 7.6 Cash flow and return measures Return on shareholders' equity, %2) 4.7 5.7 4.2 Cash Conversion, % 100.4 105.0 69.2 63.7 79.3 Operating Capital 12,442 12,457 12,456 Return on operating capital, %2) 7.2 7.7 6.7 Capital Structure Interest-bearing net debt 4,240 4,500 4,255 Interest-coverage ratio, multiple2) 4.2 4.7 4.0 Net debt/equity ratio, multiple 0.5 0.6 0.6 Net debt/adjusted EBITDA, multiple1, 2) 2.2 2.2 2.2 Equity/asset ratio, % 50.3 49.5 49.8 Equity per share, SEK 29.5 27.6 27.4 Other Number of shares 272,369,573 272,369,573 272,369,573 Number of employees, average2) 6,936 6,996 6,942 1. Before exceptional items. See Alternative performance measures on page 18 and definitions on page 21. 2. Rolling 12 months.
Page 18
ARJO INTERIM REPORT JANUARY-SEPTEMBER 202618 Q3 ALTERNATIVE PERFORMANCE MEASURES Alternative performance measures refer to financial measures used by the company's management and investors to evaluate the Group's earnings and financial position, and that cannot be directly read or derived from the financial statements. These financial measures are intended to facilitate analysis of the Group's performance. The alternative performance measures should not be considered substitutes, but rather a supplement to, the financial statements prepared in accordance with IFRS. The financial measures recognized in this report may differ from similar measures used by other companies. The alternative performance measures presented below have not been calculated in accordance with IFRS but are provided because Arjo considers them important to investors’ assessment of the Company and its share. Adjusted EBITDA/EBITA/EBIT SEK M Quarter 3 2026 Quarter 3 2025 Jan - Sep 2026 Jan - Sep 2025 Full-year 2025 EBITDA 483 425 1,415 1,311 1,811 Depreciation and impairment of tangible assets -210 -209 -615 -630 -840 EBITA 273 215 800 681 971 Amortization and write-down of intangible assets -67 -63 -199 -187 -296 Operating profit (EBIT) 206 152 601 494 675 Exceptional items1) 41 13 47 87 155 Add-back of write-down of exceptional items - -2 - -2 -44 Adjusted EBITDA 523 436 1,462 1,396 1,922 Adjusted EBITA 314 228 847 768 1,091 Adjusted operating profit (EBIT) 247 165 648 581 831 Cash conversion Quarter 3 2026 Quarter 3 2025 Jan - Sep 2026 Jan - Sep 2025 Full-year 2025 Cash flow from operations, SEK M 485 446 979 835 1,435 Operating profit (EBIT), SEK M 206 152 601 494 675 Add-back of amortization and write-down of intangible assets and tangible assets, SEK M 277 273 813 817 1,136 EBITDA, SEK M 483 425 1,415 1,311 1,811 Cash conversion, % 100.4 105.0 69.2 63.7 79.3 Net debt/equity ratio Sep 30, 2026 Sep 30, 2025 Dec 31, 2025 Interest-bearing net debt, SEK M 4,240 4,500 4,255 Shareholders’ equity, SEK M 8,029 7,519 7,457 Net debt/equity ratio, multiple 0.5 0.6 0.6 Calculation of return on operating capital Jan - Sep 2026 Jan - Sep 2025 Full-year 2025 Total assets opening balance, SEK M 15,190 15,677 16,276 Total assets closing balance, SEK M 15,953 15,190 14,977 Average total assets, SEK M 15,571 15,433 15,626 Average total assets, SEK M 15,571 15,433 15,626 Excluding average cash and cash equivalents, SEK M -782 -712 -864 Excluding average other provisions, SEK M -309 -265 -317 Excluding average other non-interest-bearing liabilities, SEK M -2,039 -2,000 -1,990 Average operating capital, SEK M 12,442 12,457 12,456 Operating profit (EBIT), SEK M2) 783 781 675 Add-back of exceptional items, SEK M2) 115 176 155 EBIT after add-back of exceptional items, SEK M 897 956 831 Return on operating capital, % 7.2 7.7 6.7 1. Refer to Note 5 Exceptional items. 2. Rolling 12 months.
Page 19
ARJO INTERIM REPORT JANUARY-SEPTEMBER 202619 Q3 9 Financial data per quarter SEK M Quarter 1 2025 Quarter 2 2025 Quarter 3 2025 Quarter 4 2025 Quarter 1 2026 Quarter 2 2026 Quarter 3 2026 Net sales 2,863 2,678 2,646 2,814 2,698 2,759 2,849 Cost of goods sold -1,613 -1,516 -1,558 -1,629 -1,549 -1,596 -1,624 Gross profit 1,250 1,162 1,088 1,185 1,149 1,163 1,226 Operating expenses -1,010 -951 -925 -928 -961 -956 -984 Exceptional items -40 -34 -13 -68 -6 0 -41 Other operating income/expenses -32 -3 2 -7 3 4 5 Operating profit (EBIT) 168 174 152 182 184 211 206 Net financial items -43 -48 -41 -77 -36 -40 -102 Profit after financial items 125 126 111 104 148 171 104 Taxes -34 -34 -30 -34 -40 -46 -46 Net Profit for the period 91 92 81 70 108 125 58 Adjusted EBITDA1) 486 475 436 526 456 482 523 Adjusted EBITDA margin, %1) 17.0 17.7 16.5 18.7 16.9 17.5 18.4 1. EBITDA before exceptional items. Refer to Note 5 Exceptional items, Alternative performance measures on page 18 and definitions on page 21. 10 Transactions with related parties SEK M Quarter 3 2026 Quarter 3 2025 Jan - Sep 2026 Jan - Sep 2025 Full-year 2025 Sales 5 3 16 18 23 Purchases of goods -3 -4 -9 -9 -10 Accounts receivable 0 0 3 2 2 Accounts payable 0 0 2 1 1 Carl Bennet AB is the parent company and has a controlling influence over the Arjo Group. In addition to the customary dividend to Carl Bennet AB, Arjo has conducted transactions with companies within the Getinge Group, over which Carl Bennet AB also has a controlling influence. Arjo uses Getinge as a distributor in certain markets. Transactions involving the delivery of products and services between the groups are carried out on commercial terms and at market-based prices. Transactions with the Getinge Group are specified in the table above. Apart from the above, no other material related-party transactions have taken place. 11 Acquisitions Acquisitions 2026 During the second quarter, Arjo acquired parts of the business of the Australian company M and D Miscevic Pty Ltd (MD Engineering Solutions), which provides service of medical devices. The purchase price amounted to SEK 30 M. The acquisition was structured as an asset deal and has been integrated into Arjo’s existing operations in Australia since June 1. The acquired business generates annual sales of approximately SEK 12 M. As the acquisition is not considered material in relation to Arjo, no further disclosures are provided in this report. Acquisitions 2025 During the third quarter, Arjo acquired parts of the business of the Australian company Arden Maintenance Services Pty Ltd, which provides service of medical devices. The purchase price amounted to SEK 5 M. The acquisition was made as an asset deal and was integrated into Arjo’s existing operations in Australia. The acquired business generates annual sales of approximately SEK 3 M. During the fourth quarter, all shares in the three Dutch companies SlingCare B.V., SlingCare Products B.V. and Josh IP B.V., which specialize in patient handling solutions, were acquired. The purchase price amounted to SEK 19 M and annual sales amount to approximately SEK 6 M. During the second quarter of 2025, a purchase price adjustment of SEK 2 M was recognized in relation to an acquisition completed in 2024.
Page 20
ARJO INTERIM REPORT JANUARY-SEPTEMBER 202620 Q3 Parent Company financial statements CONDENSED PARENT COMPANY INCOME STATEMENT SEK M Quarter 3 2026 Quarter 3 2025 Jan - Sep 2026 Jan - Sep 2025 Full-year 2025 Net sales - - - - 320 Administrative expenses -52 -35 -146 -112 -393 Exceptional items1) -35 -1 -35 -33 -33 Other operating income and expenses 0 0 -2 0 -1 Operating loss (EBIT) -87 -36 -183 -145 -107 Income from participations in Group companies 208 17 425 296 471 Net financial items2) -60 -17 -90 -56 -76 Profit after financial items 61 -36 152 95 288 Taxes 21 10 46 41 -4 Net Profit for the period3) 82 -26 198 135 284 1. Exceptional items refer to restructuring costs. 2. Net financial items contain interest income, interest expenses, other financial expenses and exchange-rate gains and losses attributable to the translation of financial receivables and liabilities in foreign currencies measured at the closing day rate. 3. Also comprehensive income for the period. CONDENSED PARENT COMPANY BALANCE SHEET SEK M Sep 30, 2026 Sep 30, 2025 Dec 31, 2025 Assets Intangible assets 418 379 384 Financial assets 5,996 6,049 5,994 Non-current financial receivables, Group companies 2,000 1,000 2,000 Total non-current assets 8,413 7,428 8,377 Other current receivables, Group companies 303 184 306 Current receivables 54 48 44 Total current assets 358 232 350 Total assets 8,771 7,660 8,727 Shareholders' equity and liabilities Shareholders' equity 4,523 4,434 4,583 Non-current financial liabilities 2,000 1,000 2,000 Provisions, non-current 3 3 3 Total non-current liabilities 2,003 1,003 2,003 Provisions, current - 5 4 Current financial liabilities 1,397 1,283 845 Current financial liabilities, Group companies 761 882 1,244 Other current liabilities, Group companies 12 15 14 Other non-interest-bearing liabilities 75 37 34 Total current liabilities 2,245 2,222 2,141 Total shareholders' equity and liabilities 8,771 7,660 8,727 The Parent Company’s commercial paper program has a framework amount of SEK 5,000 M (5,000). The total amount issued at the end of the period amounted to SEK 1,396 M (1,285). The Parent Company’s MTN program has a framework amount of SEK 5,000 M (5,000). The total amount issued at the end of the period amounted to SEK 2,000 M (1,000).
Page 21
Q3 ARJO INTERIM REPORT JANUARY–SEPTEMBER 2026 21 Definitions FINANCIAL TERMS Adjusted EBIT/Operating profit Operating profit with add-back of exceptional items. Adjusted EBITA EBITA with add-back of exceptional items. Adjusted EBITA margin Adjusted EBITA in relation to net sales. Adjusted EBITDA EBITDA with add-back of exceptional items. Adjusted EBITDA margin Adjusted EBITDA in relation to net sales. Cash conversion Cash flow from operations in relation to EBITDA. EBIT Operating profit. EBITA Operating profit before amortization and write-down of intangible assets. EBITA margin EBITA in relation to net sales. EBITDA Operating profit before amortization, depreciation and write-down. EBITDA margin EBITDA in relation to net sales. Exceptional items Total of acquisition and restructuring costs as well as major non-recurring items. Earnings per share Profit for the period attributable to Parent Company shareholders in relation to average number of shares. The following data was used to calculate earnings per share for the period: Profit for the period attributable to Parent Company shareholders SEK 291 M Number of shares, thousands 272,370 Earnings per share SEK 1.07 Equity/assets ratio Shareholders’ equity in relation to total assets. Interest-coverage ratio Profit after financial items plus interest expenses and add-back of exceptional items in relation to interest expenses. Calculated based on rolling twelve- month data. Net debt/adjusted EBITDA Average net debt in relation to rolling 12 months’ adjusted EBITDA. Net debt/equity ratio Interest-bearing net debt in relation to shareholders’ equity. Operating capital Average total assets less cash and cash equivalents, other provisions, accounts payable and other non-interest-bearing liabilities. Organic change A financial change adjusted for currency fluctuations, acquisitions and divestments. Operating expenses Selling expenses, administrative expenses and research and development costs. Operating margin Operating profit in relation to net sales. Return on operating capital Rolling 12 months’ operating profit with add-back of exceptional items in relation to operating capital. Return on shareholders’ equity Rolling 12 months’ profit after tax in relation to average shareholders’ equity. MEDICAL AND OTHER TERMS Arjo Insight Arjo’s evidence-based assessment tool for identifying risks at healthcare facilities and providing a recommendation on which equipment is needed to reduce the risk of, for example, work-related injuries or a reduction in the healthcare quality. Compression therapy Treatment technique which means that one uses outer pressure with a certain frequency and for a certain period of time to treat and prevent venous leg ulcers. DVT (deep vein thrombosis) Formation of a blood clot in one of the body’s deep veins, often in the leg. Ergonomics A science concerned with designing the job to fit the worker to prevent illness and accidents. ESG An abbreviation that stands for environmental, social and governance, which are the non-financial factors in corporate reporting. EU Medical Device Regulation (MDR) Regulations created by the EU to ensue better protection for the public health and patient safety by establishing modernized and more robust EU legislation. All medical device manufacturers and distributors must comply with these regulations. Intermittent pneumatic VTE prevention A treatment that aims to enhance the circulation of blood in the deep veins of the legs, which helps reduce deep vein thrombosis (blood clot in the deep veins of the legs). US Food and Drug Administration (FDA) The US authority responsible for protecting the public health by carrying out regular inspections of, among other things, medical devices. Pressure injuries Sores that occur when blood flow to the skin is reduced by external pressure. Most common in patients with reduced mobility. Prevention Preventive activity/treatment. VTE (venous thromboembolism) The abbreviation VTE standards for venous thromboembolism – a blood clot in the veins, similar to DVT (above).
Page 22
Q3 ARJO INTERIM REPORT JANUARY–SEPTEMBER 2026 22 TELECONFERENCE Fund managers, analysts and the media are invited to a teleconference on October 22 at 08:00 CEST. A presentation will be held during the teleconference. Watch the teleconference via the following link: https:/ /events.inderes.com/arjo/q3-report-2026 Participants who wish to ask verbal questions at the teleconference must register using the link below. Once registered, participants will receive a telephone number and ID number to use to log in to the conference. Registration link: https:/ /events.inderes.com/arjo/q3-report-2026/dial-in Alternatively, use the following link to download the presentation: https:/ /www.arjo.com/int/about-us/investors/reports-- presentations/2026/ A recording of the teleconference will be available for three years via the following link: https:/ /events.inderes.com/arjo/q3-report-2026 FINANCIAL INFORMATION Updated information on, for example, the Arjo share and corporate governance is available on Arjo’s website www.arjo.com . The Annual Report, year-end report and interim reports are published in Swedish and English and are available for download at www.arjo.com . The following financial statements will be published in 2026/2027: January 28, 2027 Year-end report 2026 March-April 2027 2026 Annual Report April 16, 2027 Interim report Jan–Mar 2027 April 19, 2027 Annual General Meeting 2027 CONTACT Maria Nilsson Executive Vice President, Communication & Public Relations +46 734 244 515 maria.nilsson@arjo.com Erik Roslund Investor Relations & Corporate Communications Manager +46 768 996 303 erik.roslund@arjo.com This information is information that Arjo AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, on October 22, 2026 at 07:00 a.m. CEST. At Arjo, we believe that empowering movement within healthcare environments is essential to quality care. Our products and solutions for patient transfers, hygiene, disinfection, diagnostics, treating leg ulcers, prevention of pressure injuries and deep vein thrombosis, and our medical beds are all designed to promote mobility, safety and dignity in all care situations. With over 7,000 people worldwide and 65 years caring for patients and healthcare professionals, we are committed to driving healthier outcomes for people facing mobility challenges. Arjo AB · Corp. Reg. No. 559092–8064 · Hans Michelsensgatan 10 · SE-211 20 Malmö · Sweden www.arjo.com